Key facts
- This page summarizes Daniel E. Geffken's Form 3 filing for CalciMedica, Inc. (CALC).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 May 2023, 20:55.
Daniel E. Geffken - 20 Mar 2023 Form 3 Insider Report for CalciMedica, Inc. (CALC)
- Reporting relationship
- Interim CFO
- Issuer ticker
- CALC
- Reported as of
- 20 Mar 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 03 May 2023, 20:55:57 UTC
- Prior SEC filing
- 07 Jul 2022
- Next SEC filing
- 29 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- John Dunn, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel E. Geffken filed Form 3 for CalciMedica, Inc. (CALC) on 03 May 2023.
Change
- Previous filing in this sequence was filed on 07 Jul 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CALC
holding
Derivative
Warrant
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 20 Mar 2023
- Ownership
- By SG DAN Equity Holdings, LLC
- Underlying class
- Common Stock
- Underlying amount
- 1,982
- Exercise price
- $54.32
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Immediately exercisable.